clinicaltrialsarena14m
TenNor’s Phase III antibiotic trial meets all primary endpoints
The topline results found that the TenNor rifasutenizol trial showed better safety and tolerability than the current standard ...
clinicaltrialsarena2h
Gilead’s Livdelzi shows promise in PBC clinical trial
Gilead Sciences has reported two-and-a-half-year interim analysis outcomes from a Phase III study of Livdelzi (seladelpar) ...
clinicaltrialsarena4h
Eyenovia stock plummets following Phase III myopia trial failure
The failure of the Eyenovia CHAPERONE study has seen the company’s stock value drop drastically as it weighs up options and ...
clinicaltrialsarena17h
Men’s Health Awareness Month promotes early prostate cancer detection
GlobalData forecasts that the prostate cancer market is set to increase by 25% from $475.84 million in 2024 to $596.22 ...
clinicaltrialsarena17h
Intellia’s gene editing therapy shows early potential in rare heart condition
Atrial flutter is a type of abnormal heart rhythm that causes rapid and irregular beating of the upper chambers of the heart. Credit: Rawpixel.com via Shutterstock. Intellia Therapeutics has announced ...
clinicaltrialsarena17h
Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
The trial evaluated nucresiran’s safety, pharmacokinetics and pharmacodynamics in healthy individuals. Credit: Andrei_R/Shutterstock. Alnylam Pharmaceuticals has revealed new interim data from its ...
clinicaltrialsarena17h
Eli Lilly reports outcomes from Phase III trial of tirzepatide for HFpEF
The study involved 731 participants who were randomised to receive either tirzepatide or placebo. Credit: Africa Studio/Shutterstock. Eli Lilly has reported comprehensive outcomes from the Phase III ...